Variable role of the long terminal repeat Sp1-binding sites in human immunodeficiency virus replication in T lymphocytes
Authors:
- 1 March 1991
- journal article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 65 (3) , 1414-9
Abstract
The long terminal repeat (LTR) of the human immunodeficiency virus (HIV) contains three binding sites for the transcriptional factor Sp1. In order to investigate the role that the Sp1-binding sites play in regulation of HIV replication, we have introduced a deletion of all three Sp1-binding sites into the LTR of an infectious molecular clone of HIV. Viral stocks have been prepared from this mutant virus, designated dl-Sp, and these stocks have been used to study its replicative ability in human T cells. The dl-Sp virus replicated efficiently in MT4 cells and in phytohemagglutinin-stimulated human peripheral blood lymphocytes, but it replicated poorly and with delayed kinetics in A3.01 (CEM) T cells unless those cells had been treated with the cytokine tumor necrosis factor alpha. Gel retardation assays to study the levels of DNA-binding proteins present in these cells showed that NF-kappa B activity could be detected in the nuclei of MT4 cells but not in A3.01 cells unless they had been treated with tumor necrosis factor alpha. Thus, the presence of NF-kappa B activity appeared to be required for efficient replication of an HIV whose LTR Sp1-binding sites had been deleted. This suggests that NF-kappa B can functionally compensate for Sp1 in activating HIV replication. The HIV LTR is therefore similar to the promoter-enhancer units of other viruses in that it is composed of multiple functional elements that may contribute differently to viral replication depending on the levels of DNA-binding proteins present in the target cells.Keywords
This publication has 42 references indexed in Scilit:
- Cooperativity and hierarchical levels of functional organization in the SV40 enhancerCell, 1988
- Activation of the HIV-1 LTR by T Cell Mitogens and the Trans-Activator Protein of HTLV-IScience, 1987
- Transcription Directed by the HIV Long Terminal Repeat In VitroAIDS Research and Human Retroviruses, 1987
- Expression and Characterization of the Trans -Activator of HTLV-III/LAV VirusScience, 1986
- Trans-activation of human immunodeficiency virus occurs via a bimodal mechanismCell, 1986
- The SV40 enhancer is composed of multiple functional elements that can compensate for one anotherCell, 1986
- Location of the Trans -Activating Region on the Genome of Human T-Cell Lymphotropic Virus Type IIIScience, 1985
- Trans -Activator Gene of Human T-Lymphotropic Virus Type III (HTLV-III)Science, 1985
- The location of cis-acting regulatory sequences in the human T cell lymphotropic virus type III (HTLV-III/LAV) long terminal repeatCell, 1985
- Selective extraction of polyoma DNA from infected mouse cell culturesJournal of Molecular Biology, 1967